Once acquired, HTLV-1 infections persist life-long, most patients remaining asymptomatic viral reservoirs ensuring the transmission chain, but about 4% develop adult T-cell leukemia/lymphoma (ATLL), a highly aggressive CD4+ T-cell malignancy. This evidence concerns the gene CD4 and adult T-cell leukemia/lymphoma.